An IgA nephropathy case with highly reduced urinary protein concomitant with reduced obesity

Japanese Journal of Nephrology

Volumn 48, Issue 7, 2006, Pages 675-679

  Nakamura, Taichi ^a   Fujikura, Yuji ^a   Suga, Norihiro ^a   Hatazoe, Kumiko ^a   Hinoshita, Fumihiko ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; IgA nephropathy; Obesity urinary protein

Indexed keywords

ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; STEROID;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CASE REPORT; DIABETES MELLITUS; DIET; DRUG TOLERANCE; EXERCISE; FEMALE; HUMAN; HYPERLIPIDEMIA; KIDNEY BIOPSY; KIDNEY DISEASE; METABOLIC SYNDROME X; OBESITY; PROTEIN URINE LEVEL; PROTEINURIA;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; OBESITY; PROTEINURIA; WEIGHT LOSS;

EID: 33751231689     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chi-yuan H, McCulloch EC, Iribarren C, Darbinian J, Alan GS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.
2. Praga M, Gutierrez E, Gonzales E, Morales E, Hernandez E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled study. J Am Soc Nephrol 2003; 14: 1578-1583.
3. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480-1486.
4. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001; 37: 720-727.
5. Morales E, Valero MA, Leon M, Hernandez E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41: 319-327.
6. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.
7. Verani RR. Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 1992; 20: 629-634.
8. Chen J, Muntner P, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004; 140: 167-174.
9. Hall JE. The kidney hypertension, and obesity. Hypertension 2003; 41: 625-633.